Sabra Health Care REIT Inc
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
SBRA$21.32-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income (Loss)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues: | ||||
| Rental and related revenues (Note 6) | $94,555 | $93,085 | $285,427 | $283,229 |
| Resident fees and services | 73,746 | 59,748 | 207,716 | 174,897 |
| Interest and other income | 9,700 | 8,794 | 27,746 | 25,991 |
| Total revenues | 178,001 | 161,627 | 520,889 | 484,117 |
| Expenses: | ||||
| Depreciation and amortization | 42,720 | 43,242 | 127,315 | 140,211 |
| Interest | 29,467 | 28,156 | 87,189 | 85,024 |
| Triple-net portfolio operating expenses | 4,270 | 4,304 | 12,992 | 13,243 |
| Senior housing - managed portfolio operating expenses | 54,234 | 44,523 | 154,258 | 132,124 |
| General and administrative | 12,404 | 10,759 | 37,035 | 30,793 |
| (Recovery of) provision for loan losses | (148) | 328 | (446) | 549 |
| Impairment of real estate | — | — | 18,472 | 7,064 |
| Total expenses | 142,947 | 131,312 | 436,815 | 409,008 |
| Other income (expense): | ||||
| Loss on extinguishment of debt | — | — | — | (1,541) |
| Other income | — | 2,229 | 838 | 2,570 |
| Net loss on sales of real estate | (5,745) | (46,545) | (3,969) | (75,893) |
| Total other expense | (5,745) | (44,316) | (3,131) | (74,864) |
| Income (loss) before income (loss) from unconsolidated joint ventures and income tax benefit (expense) | 29,309 | (14,001) | 80,943 | 245 |
| Income (loss) from unconsolidated joint ventures | 214 | (645) | (301) | (2,136) |
| Income tax benefit (expense) | 265 | (455) | (625) | (1,509) |
| Net income (loss) | $29,788 | $(15,101) | $80,017 | $(3,400) |
| Net income (loss), per: | ||||
| Basic common share | $0.13 | $(0.07) | $0.34 | $(0.01) |
| Diluted common share | $0.13 | $(0.07) | $0.34 | $(0.01) |
| Weighted average number of common shares outstanding, basic | 234,290,187 | 231,224,692 | 232,459,388 | 231,197,375 |
| Weighted average number of common shares outstanding, diluted | 237,043,400 | 231,224,692 | 234,777,101 | 231,197,375 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.